Jean‐Michel Dogné

Targeting tumor-associated carbonic anhydrase IX in cancer therapy

Anne Thiry, Jean‐Michel Dogné, Bernard Masereel et al. · Trends in Pharmacological Sciences · 2006 · 392 citations

Cancer Therapy, Tumor Targeting, Anti-cancer Agent +4

Impact of dabigatran on a large panel of routine or specific coagulation assays

Bernard Châtelain, Jean‐Michel Dogné · Thrombosis and Haemostasis · 2012 · 319 citations

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

C Chatelain, Bernard Châtelain, Jonathan Douxfils et al. · Thrombosis and Haemostasis · 2013 · 207 citations · Full text

Pharmacotherapy, Thrombosis, Immunological Assays +17

Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival

Jonathan Douxfils, Hélène Haguet, François Mullier et al. · JAMA Oncology · 2016 · 186 citations · Full text

Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation

Ludwig J. Dubois, Sarah G.J.A. Peeters, Natasja G. Lieuwes et al. · Radiotherapy and Oncology · 2011 · 166 citations · Full text

Specific Inhibition, Vivo Therapeutic Effect, Biochemistry +10